Financials data is unavailable for this security.
View more
Year on year Rua Life Sciences PLC grew revenues 34.09% from 1.63m to 2.18m while net income improved from a loss of 2.07m to a smaller loss of 2.00m.
Gross margin | 81.97% |
---|---|
Net profit margin | -100.05% |
Operating margin | -135.37% |
Return on assets | -32.95% |
---|---|
Return on equity | -40.56% |
Return on investment | -36.33% |
More ▼
Cash flow in GBPView more
In 2023, cash reserves at Rua Life Sciences PLC fell by 1.48m. Cash Flow from Financing totalled 132.00k or 6.06% of revenues. In addition the company used 1.15m for operations while cash used for investing totalled 477.00k.
Cash flow per share | -0.0677 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.1683 |
---|---|
Tangible book value per share | 0.1347 |
More ▼
Balance sheet in GBPView more
Current ratio | 2.67 |
---|---|
Quick ratio | 2.40 |
Total debt/total equity | 0.1192 |
---|---|
Total debt/total capital | 0.1065 |
More ▼